BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19114209)

  • 1. Blockade of receptor for advanced glycation end product attenuates pulmonary reperfusion injury in mice.
    Sternberg DI; Gowda R; Mehra D; Qu W; Weinberg A; Twaddell W; Sarkar J; Wallace A; Hudson B; D'Ovidio F; Arcasoy S; Ramasamy R; D'Armiento J; Schmidt AM; Sonett JR
    J Thorac Cardiovasc Surg; 2008 Dec; 136(6):1576-85. PubMed ID: 19114209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice.
    Zeng S; Feirt N; Goldstein M; Guarrera J; Ippagunta N; Ekong U; Dun H; Lu Y; Qu W; Schmidt AM; Emond JC
    Hepatology; 2004 Feb; 39(2):422-32. PubMed ID: 14767995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute hyperglycemic exacerbation of lung ischemia-reperfusion injury is mediated by receptor for advanced glycation end-products signaling.
    Lapar DJ; Hajzus VA; Zhao Y; Lau CL; French BA; Kron IL; Sharma AK; Laubach VE
    Am J Respir Cell Mol Biol; 2012 Mar; 46(3):299-305. PubMed ID: 21980055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor for advanced glycation end product (RAGE)-dependent modulation of early growth response-1 in hepatic ischemia/reperfusion injury.
    Zeng S; Dun H; Ippagunta N; Rosario R; Zhang QY; Lefkowitch J; Yan SF; Schmidt AM; Emond JC
    J Hepatol; 2009 May; 50(5):929-36. PubMed ID: 19303658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of soluble receptor for advanced glycation end products on endotoxin-induced lung injury.
    Zhang H; Tasaka S; Shiraishi Y; Fukunaga K; Yamada W; Seki H; Ogawa Y; Miyamoto K; Nakano Y; Hasegawa N; Miyasho T; Maruyama I; Ishizaka A
    Am J Respir Crit Care Med; 2008 Aug; 178(4):356-62. PubMed ID: 18535257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor for advanced glycation end products involved in lung ischemia reperfusion injury in cardiopulmonary bypass attenuated by controlled oxygen reperfusion in a canine model.
    Rong J; Ye S; Liang MY; Chen GX; Liu H; Zhang JX; Wu ZK
    ASAIO J; 2013; 59(3):302-8. PubMed ID: 23644619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model.
    Aleshin A; Ananthakrishnan R; Li Q; Rosario R; Lu Y; Qu W; Song F; Bakr S; Szabolcs M; D'Agati V; Liu R; Homma S; Schmidt AM; Yan SF; Ramasamy R
    Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1823-32. PubMed ID: 18245563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor for advanced-glycation end products: key modulator of myocardial ischemic injury.
    Bucciarelli LG; Kaneko M; Ananthakrishnan R; Harja E; Lee LK; Hwang YC; Lerner S; Bakr S; Li Q; Lu Y; Song F; Qu W; Gomez T; Zou YS; Yan SF; Schmidt AM; Ramasamy R
    Circulation; 2006 Mar; 113(9):1226-34. PubMed ID: 16505177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-mobility group box-1 in ischemia-reperfusion injury of the heart.
    Andrassy M; Volz HC; Igwe JC; Funke B; Eichberger SN; Kaya Z; Buss S; Autschbach F; Pleger ST; Lukic IK; Bea F; Hardt SE; Humpert PM; Bianchi ME; Mairbäurl H; Nawroth PP; Remppis A; Katus HA; Bierhaus A
    Circulation; 2008 Jun; 117(25):3216-26. PubMed ID: 18574060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The alternative crosstalk between RAGE and nitrative thioredoxin inactivation during diabetic myocardial ischemia-reperfusion injury.
    Liu Y; Qu Y; Wang R; Ma Y; Xia C; Gao C; Liu J; Lian K; Xu A; Lu X; Sun L; Yang L; Lau WB; Gao E; Koch W; Wang H; Tao L
    Am J Physiol Endocrinol Metab; 2012 Oct; 303(7):E841-52. PubMed ID: 22829582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptors for advanced glycation end-products targeting protect against hyperoxia-induced lung injury in mice.
    Reynolds PR; Schmitt RE; Kasteler SD; Sturrock A; Sanders K; Bierhaus A; Nawroth PP; Paine R; Hoidal JR
    Am J Respir Cell Mol Biol; 2010 May; 42(5):545-51. PubMed ID: 19541845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end products accelerate ischemia/reperfusion injury through receptor of advanced end product/nitrative thioredoxin inactivation in cardiac microvascular endothelial cells.
    Liu Y; Ma Y; Wang R; Xia C; Zhang R; Lian K; Luan R; Sun L; Yang L; Lau WB; Wang H; Tao L
    Antioxid Redox Signal; 2011 Oct; 15(7):1769-78. PubMed ID: 21126209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha from resident lung cells is a key initiating factor in pulmonary ischemia-reperfusion injury.
    Maxey TS; Enelow RI; Gaston B; Kron IL; Laubach VE; Doctor A
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):541-7. PubMed ID: 14762366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of lung mechanical properties and alveolar architecture on the pathogenesis of ischemia-reperfusion injury.
    Silva CA; Carvalho RS; Cagido VR; Zin WA; Tavares P; DeCampos KN
    Interact Cardiovasc Thorac Surg; 2010 Jul; 11(1):46-51. PubMed ID: 20378696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor for advanced glycation end products (RAGE) on iNKT cells mediates lung ischemia-reperfusion injury.
    Sharma AK; LaPar DJ; Stone ML; Zhao Y; Kron IL; Laubach VE
    Am J Transplant; 2013 Sep; 13(9):2255-67. PubMed ID: 23865790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 4 mediates lung ischemia-reperfusion injury.
    Shimamoto A; Pohlman TH; Shomura S; Tarukawa T; Takao M; Shimpo H
    Ann Thorac Surg; 2006 Dec; 82(6):2017-23. PubMed ID: 17126102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine A2A receptor activation reduces inflammation and preserves pulmonary function in an in vivo model of lung transplantation.
    Reece TB; Ellman PI; Maxey TS; Crosby IK; Warren PS; Chong TW; LeGallo RD; Linden J; Kern JA; Tribble CG; Kron IL
    J Thorac Cardiovasc Surg; 2005 May; 129(5):1137-43. PubMed ID: 15867791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAGE blockade and hepatic microcirculation in experimental endotoxaemic liver failure.
    Kuhla A; Norden J; Abshagen K; Menger MD; Vollmar B
    Br J Surg; 2013 Aug; 100(9):1229-39. PubMed ID: 23804133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of gabexate mesilate (FOY) on ischemia-reperfusion-induced acute lung injury in dogs.
    Luh SP; Tsai CC; Shau WY; Chen JS; Kuo SH; Lin-Shiau SY; Lee YC
    J Surg Res; 1999 Dec; 87(2):152-63. PubMed ID: 10600344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling.
    Volz HC; Laohachewin D; Seidel C; Lasitschka F; Keilbach K; Wienbrandt AR; Andrassy J; Bierhaus A; Kaya Z; Katus HA; Andrassy M
    Basic Res Cardiol; 2012 Mar; 107(2):250. PubMed ID: 22318783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.